FDA Approves Zurzuvae, an Oral Treatment for Postpartum Depression
The FDA has approved Zurzuvae (zuranolone) for the treatment of postpartum depression in adults.
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved Zurzuvae (zuranolone) for the treatment of postpartum depression in adults.
Vigadrone (vigabatrin), an AB-rated generic version of Sabril, is now available as a 500mg tablet in addition to the powder for oral solution formulation.
The DEA and FDA addressed the Adderall shortage, urging drugmakers to boost production of stimulants and providers to develop alternative ADHD treatments.
Vigadrone (vigabatrin), an AB-rated generic version of Sabril, is now available as a 500mg tablet in addition to the powder for oral solution formulation.
-- Approval Based on Clinically Meaningful Overall Survival Benefit Demonstrated in the TROPiCS-02 Study in Pre-Treated HR+/HER2- Metastatic Breast Cancer vs. Physician’s Choice of Chemotherapy...